Deoxycholic acid is a secondary bile acid that aids in the emulsification of fat for absorption
in the intestine. In 2015, Health Canada approved non-animal, non-human, synthetically …

Since its approval by the FDA in 2015, deoxycholic acid (DCA) has become a mainstay in
treating submental adiposity. In addition, as with many products and procedures in our …

Background Synthetic deoxycholic acid (DCA) has been approved as an injectable drug for
the nonsurgical reduction of submental fat. Objective In this study, we evaluated the fat …

Deoxycholic acid (DCA; Kybella, Allergan Pharmaceuticals, Irvine, CA, USA) is an injectable
medication approved for the reduction of submental fat. DCA was approved by the US Food …

Alternative Cosmetic and Medical Applications of Injectable... : Dermatologic Surgery
Alternative Cosmetic and Medical Applications of Injectable Deoxycholic Acid: A Systematic …

Background Deoxycholic acid (DCA) was developed by the pharmaceutical industry for
aesthetical use in submental fat reduction. It represents the first lipolytic substance approved …

Deoxycholic acid (DCA; Kybella, Allergan Pharmaceuticals, Irvine, CA) is a novel injectable
medication approved for reduction of submental fat. It is the first and only pharmaceutical …

Deoxycholic acid (DCA) is a noninvasive treatment for unwanted localized subcutaneous fat,
which has shown great efficacy in reducing submental fullness. Deoxycholic acid (Kybella; …

Introduction: Injectable deoxycholic acid (DCA; Kybella; Allergan, Irvine, CA) is currently
approved only for treatment of persistent submental fat (SMF). Many cosmetic surgeons use …